Are serum biomarkers accurate enough to detect Oral Cancer early?
Serum biomarkers are substances in the blood that may signal the presence of cancer. For oral cancer, researchers are studying many different biomarkers, but no single one is accurate enough to reliably detect the disease early. A 2025 systematic review found that individual biomarkers have variable sensitivity and specificity, and many studies have a moderate to high risk of bias 4. Combining several biomarkers into a panel can improve accuracy, but these tests are not yet ready for routine screening.
What the research says
A 2025 systematic review and meta-analysis evaluated the diagnostic ability of various serum biomarkers for oral squamous cell carcinoma (OSCC) 4. The review included 23 studies with over 3,300 participants. It found that biomarkers such as CYFRA 21-1, interleukins, and microRNAs showed variable sensitivity and specificity. The quality of the included studies was moderate to high risk of bias, meaning the results should be interpreted cautiously 4.
One study from 2021 identified a panel of six microRNAs (miR-24, miR-20a, miR-122, miR-150, miR-4419a, and miR-5100) that could distinguish OSCC patients from healthy controls with an area under the curve (AUC) of 0.844, sensitivity of 55%, and specificity of 92.5% 7. This panel performed better than the traditional serum marker SCC antigen, especially for early detection 7. However, a sensitivity of 55% means it would miss nearly half of cancer cases.
Newer technologies are also being explored. For example, a 2024 study developed a dual-signal amplification biosensor using upconversion nanoparticles to detect microRNA-222 in serum, with results similar to PCR 8. Additionally, artificial intelligence combined with surface-enhanced Raman spectroscopy (SERS) is being investigated to analyze serum and other samples for cancer biomarkers, offering a rapid and scalable approach 6. These methods are still in the research phase.
Overall, while serum biomarkers show promise, current evidence does not support their use alone for early oral cancer detection. Combining multiple biomarkers or using advanced technologies may improve accuracy, but more high-quality studies are needed.
What to ask your doctor
- What are the current standard methods for screening or detecting oral cancer early?
- Are there any blood tests available that can help detect oral cancer, and how accurate are they?
- Should I consider any specific biomarker tests if I have risk factors for oral cancer?
- What are the limitations of using serum biomarkers for oral cancer detection?
- Are there any clinical trials testing new biomarker panels for oral cancer that I might join?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.